In recognition of World Kidney Day, the National Kidney Foundation (NKF) and Healthy.io are proud to partner in offering free ...

Proteomics International aptly has chosen World Kidney Day to launch its predictive test for diabetic kidney disease locally.

FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Furosemide injection was previously approved to treat congestion from fluid buildup in adults with chronic heart failure.

The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.  Obinutuzumab is a monoclonal ...

The Furoscix 80 mg/10 ml subcutaneous injection is intended for oedema in adult CKD patients, including those with nephrotic ...

(RTTNews) - scPharmaceuticals Inc. (SCPH) announced that the U.S. Food and Drug Administration (FDA) has approved ... of edema in patients with chronic kidney disease (CKD). SCPH closed ...

The US regulator has started a review of Roche's supplemental biologics license application (BLA) for Gazyva/Gazyvaro ...

Cardiorenal specialist scPharmaceuticals has won US Food and Drug Administration (FDA) approval for its supplemental New Drug Application (sNDA) for Furoscix (furosemide injection) to expand the ...

Two recent documents—one from the FDA, the other from a commission organized by The Lancet Diabetes & Endocrinology—indicate ...

The Food and Drug Administration (FDA) has expanded the approval of Furoscix® (furosemide injection) to include the treatment of edema in patients with ...

An artistic rendering of AION Healthspan`s REJUVXL Cell Therapy for Chronic Kidney Disease. AION Healthspan announces enrollment for its fi ...